<SEC-DOCUMENT>0001213900-23-027351.txt : 20230405
<SEC-HEADER>0001213900-23-027351.hdr.sgml : 20230405
<ACCEPTANCE-DATETIME>20230405085552
ACCESSION NUMBER:		0001213900-23-027351
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20230405
FILED AS OF DATE:		20230405
DATE AS OF CHANGE:		20230405

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Moolec Science SA
		CENTRAL INDEX KEY:			0001937737
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			N4
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41586
		FILM NUMBER:		23801287

	BUSINESS ADDRESS:	
		STREET 1:		17, BOULEVARD F.W. RAIFFEISAN
		CITY:			LUXEMBOURG
		STATE:			N4
		ZIP:			L-2411
		BUSINESS PHONE:		352 26 49 65 65

	MAIL ADDRESS:	
		STREET 1:		17, BOULEVARD F.W. RAIFFEISAN
		CITY:			LUXEMBOURG
		STATE:			N4
		ZIP:			L-2411
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea176549-6k_moolecsci.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form&nbsp;6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Report of Foreign Private Issuer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pursuant to Rules&nbsp;13a-16 or 15d-16 under</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>the Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the month of April 2023</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Commission File Number: 001-41586</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MOOLEC SCIENCE SA </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of Registrant as Specified in Its Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>17, Boulevard F. W. Raiffeisen</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>L-2411 Luxembourg,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Grand Duchy of Luxembourg</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant files or will file annual reports under cover Form&nbsp;20-F or Form&nbsp;40-F.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: center; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&nbsp;20-F&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Form&nbsp;40-F&nbsp;&nbsp;&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is submitting the Form&nbsp;6-K in paper as permitted by Regulation S-T Rule&nbsp;101(b)(1): &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is submitting the Form&nbsp;6-K in paper as permitted by Regulation S-T Rule&nbsp;101(b)(7): &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION CONTAINED IN THIS REPORT ON FORM
6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On April 5, 2023, Moolec Science SA (the &ldquo;Company&rdquo;)
issued a press release announcing the U.S. Department of Agriculture&rsquo;s (&ldquo;USDA&rdquo;) Animal Plant Health Inspection Service
(&ldquo;APHIS&rdquo;) review response of one of the Company&rsquo;s products. A copy of the press release is furnished as Exhibit 99.1
to this Report on Form 6-K and incorporated by reference herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Exhibit List</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit No.</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="ea176549ex99-1_moolecsci.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release of Moolec Science SA dated April 5, 2023.</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">MOOLEC SCIENCE SA</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">(Registrant)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Dated: April 5, 2023</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">/s/ Gast&oacute;n Paladini</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:&nbsp; </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Gast&oacute;n Paladini</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea176549ex99-1_moolecsci.htm
<DESCRIPTION>PRESS RELEASE OF MOOLEC SCIENCE SA DATED APRIL 5, 2023
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 14.25pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 14.25pt"><B>&nbsp;<IMG SRC="ex99-1_001.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 14.25pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 14.25pt"><B>Moolec Science Achieves
USDA-APHIS Regulatory Status Review</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 14.25pt"><B>Clearance for Molecular Farming Product</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B>Luxembourg.
April 5, 2023</B> - Moolec Science SA (NASDAQ: MLEC; &ldquo;Company&rdquo; or &ldquo;Moolec&rdquo;), a Molecular Farming food-ingredient
company, announced today that the Animal and Plant Health Inspection Service (&ldquo;APHIS&rdquo;) of the U.S. Department of Agriculture
(&ldquo;USDA&rdquo;) has concluded that Moolec&rsquo;s GLA safflower plants pose no greater plant pest risk than non-genetically engineered
safflower plants according to regulation found at 7 CFR part 340. To access the Regulatory Status Review (&ldquo;RSR&rdquo;) response
from USDA-APHIS, click here.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Moolec&rsquo;s
CEO &amp; Co-Founder Gast&oacute;n Paladini stated: &ldquo;This important milestone reinforces our go-to-market path and validates our
proposed regulatory strategy. Also, it complements the FDA&rsquo;s food safety reviews and approvals already obtained for our GLA safflower
oil (GLASO).&rdquo; He finished by declaring: &ldquo;The green light from USDA-APHIS bolsters the idea of the safe use of Molecular Farming
technology to improve nutritional profile for end food products. Moolec is very excited that its innovative food ingredients are a key
part of the bioeconomy.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">Martin Salinas,
Chief of Technology &amp; Co-Founder of Moolec, expressed: &ldquo;This will greatly increase the efficiency of our operations, including
raw material procurement, downstream crushing, and processing. We will no longer need USDA-APHIS permits to import, move interstate, or
grow these plants in the field in the United States.&rdquo; He concluded: &ldquo;We are positive that this achievement paves the way for
our upcoming regulatory reviews in our pipeline.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">According
to USDA-APHIS regulation found at 7 CFR part 340, developers may submit a request for a RSR when they believe a genetically engineered
(&ldquo;GE&rdquo;) plant is not subject to the regulation. APHIS reviews the GE plant and considers whether it might pose an increased
plant pest risk compared to its non-GE comparator. If APHIS does not identify a greater pest risk relative to the comparator, the GE plant
is not subject to this regulation. Regulation 7 CFR part 340 governs the importation, interstate movement, and the environmental release
of certain organisms that have been modified or produced by genetic engineering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Moolec Science SA</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Moolec is a science-based food ingredient company
focused on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape.
Its purpose is to upgrade taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable
food system. The Company&rsquo;s technological approach aims to have the cost structure of plant-based solutions with the organoleptic
properties and functionality of animal-based ones. Moolec&rsquo;s technology has been under development for more than a decade and is
known for pioneering the production of a bovine protein in a crop for the food industry. The Company&rsquo;s product portfolio and pipeline
leverages the agronomic efficiency of broadly used target crops, like safflower, soybean, and pea. Moolec has a growing international
patent portfolio (23, both granted and pending) for its Molecular Farming technology. The Company is run by a diverse team of Ph.Ds and
Food Insiders, and operates in the United States, Europe, and South America. For more information, visit www.moolecscience.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><IMG SRC="ex99-1_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release contains &ldquo;forward-looking
statements.&rdquo; Forward-looking statements may be identified by the use of words such as &ldquo;forecast,&rdquo; &ldquo;intend,&rdquo;
&ldquo;seek,&rdquo; &ldquo;target,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;expect,&rdquo; &ldquo;estimate,&rdquo;
&ldquo;plan,&rdquo; &ldquo;outlook,&rdquo; and &ldquo;project&rdquo; and other similar expressions that predict or indicate future events
or trends or that are not statements of historical matters. Such forward-looking statements with respect to performance, prospects, revenues,
and other aspects of the business of Moolec Science S.A. (&ldquo;Moolec&rdquo;) are predictions, projections and other statements about
future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Although
we believe that we have a reasonable basis for each forward-looking statement contained in this press release, we caution you that these
statements are based on a combination of facts and factors, about which we cannot be certain. We cannot assure you that the forward-looking
statements in this press release will prove accurate. These forward-looking statements are subject to a number of significant risks and
uncertainties that could cause actual results to differ materially from expected results, including, among others, changes in applicable
laws or regulations, the possibility that Moolec may be adversely affected by economic, business and/or other competitive factors, costs
related to the scaling up of Moolec&rsquo;s business and other risks and uncertainties, including those included under the header &ldquo;Risk
Factors&rdquo; in the Form F-1 Registration Statement filed with the U.S. Securities and Exchange Commission (&ldquo;SEC&rdquo;), as well
as Moolec&rsquo;s other filings with the SEC. Should one or more of these risks or uncertainties materialize, or should any of our assumptions
prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no
obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except
as may be required under applicable securities laws. Accordingly, you should not put undue reliance on these statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Moolec Media Contact</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Catalina Jones - comms@moolecscience.com</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Moolec Investor Contacts</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Mart&iacute;n Taraciuk - ir@moolecscience.com</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">Michael Bowen, ICR, LLC - MoolecIR@icrinc.com</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" != )<# 2(  A$! Q$!_\0
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M3T2)"Q_(4 >\:AXP^$GC:>#6_$5I=6VIQH!+$%;]YCH"5X8>_!KB_B5\4/\
MA*]0TZ'18&LM+TIP]J" &+C&&P.F .!7!WVBZKIBAK_3;NV4]&FA91^9%4:
M/>I_B#\.OB'I=F?&UI/9ZI:K@R0AL-Z[67G!/8CBN<^(_P 3-*U7P[;>$O"=
MF]MHD&W>[KM,FWD #KC/))Y)KRBB@#U/QGX_T;7/A1X<\/V?G_VA9B,3JR85
M-B;>#WR>E;UG\1O!WC;PK8Z3X[^VVE]8@!+RV)^? QG(S@D 9!!&:\/ +$
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KGM33I=@=0&H&RM_MJKM%QY0\P#TW8S0!;HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
